Catalyst Pharmaceuticals to Participate in the Barclays 27th Annual Global Healthcare Conference

Core Insights - Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing treatments for rare and difficult-to-treat diseases [1][3] - The company will participate in the Barclays 27th Annual Global Healthcare Conference on March 11, 2025, in Miami, Florida [1][2] - Catalyst has been recognized on the Forbes 2025 list as one of America's Most Successful Mid-Cap Companies and on the 2024 Deloitte Technology Fast 500™ list as one of North America's Fastest-Growing Companies [3] Company Overview - Catalyst Pharmaceuticals is headquartered in Coral Gables, Florida, and is committed to improving the lives of patients with rare diseases [3] - The company focuses on in-licensing, commercializing, and developing innovative therapies, ensuring patient accessibility through a comprehensive suite of support services [3] - Catalyst aims to expand its global commercial footprint through strategic partnerships while maintaining a strong presence in the U.S. market [3]